Efficacy of abatacept in systemic lupus erythematosus: a retrospective analysis of 11 patients with refractory disease
François Danion(Hôpitaux Universitaires de Strasbourg), Yves‐Marie Pers(University of Ljubljana), Rakiba Belkhir(Assistance Publique – Hôpitaux de Paris), Nicolas Rosine(Université Paris-Sud), Raphaèle Séror(Inserm), Emmanuel Chatelus(Laboratoire National de Référence), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), J.E. Gottenberg(Inserm), Xavier Mariette(Inserm), É. Hachulla(Centre Hospitalier Universitaire de Lille), G. Pugnet(Centre Hospitalier Universitaire de Toulouse)
Cited by 24
Related Papers
Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper
|Annals of Oncology|2015|897
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
|New England Journal of Medicine|2009|857
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501